Report Overview
Immuno cell therapy represents a cutting-edge segment of the biopharmaceutical industry, focusing on harnessing the body\'s immune system to target and eliminate diseases, particularly cancers and autoimmune disorders. This therapy involves modifying a patient\'s immune cells—such as T cells, NK cells, or dendritic cells—to enhance their ability to recognize and attack malignant or dysfunctional cells. Key modalities include CAR-T (chimeric antigen receptor T-cell) therapy, TCR (T cell receptor) therapy, and tumor-infiltrating lymphocyte (TIL) therapy, each leveraging different mechanisms to induce immune responses. The market has seen rapid growth due to breakthroughs in genetic engineering, increased investment in R&D, and regulatory approvals for treatments targeting hematologic malignancies. However, challenges such as high manufacturing costs, complex logistics, and limited efficacy in solid tumors remain significant barriers. The competitive landscape features both established biotech firms and emerging players, with partnerships and acquisitions driving innovation. Geographically, North America leads in adoption, followed by Europe and Asia-Pacific, where regulatory frameworks and healthcare infrastructure are evolving to support advanced therapies. Future expansion hinges on overcoming technical hurdles, improving accessibility, and demonstrating long-term clinical benefits.
The global Immuno Cell Therapy market size was estimated at USD 2971.66 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 15.23% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Immuno Cell Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Immuno Cell Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Immuno Cell Therapy market.
Global Immuno Cell Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
MEDINET Co
Erytech
Seta Clinic Group
Takeda
SBI Holdings
Oxford BioTherapeutics
Fate Therapeutics
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Beroni Group
Market Segmentation (by Type)
Passive Immune (NK, LAK etc)
Active Immune
Market Segmentation (by Application)
Oncology
Cardiovascular Disease (CVD)
Orthopedic
Wound Healing
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Immuno Cell Therapy Market
Overview of the regional outlook of the Immuno Cell Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immuno Cell Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Immuno Cell Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Immuno Cell Therapy
1.2 Key Market Segments
1.2.1 Immuno Cell Therapy Segment by Type
1.2.2 Immuno Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Immuno Cell Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Immuno Cell Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Immuno Cell Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Immuno Cell Therapy Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Immuno Cell Therapy Product Life Cycle
3.3 Global Immuno Cell Therapy Sales by Manufacturers (2020-2025)
3.4 Global Immuno Cell Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Immuno Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Immuno Cell Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Immuno Cell Therapy Market Competitive Situation and Trends
3.8.1 Immuno Cell Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Immuno Cell Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Immuno Cell Therapy Industry Chain Analysis
4.1 Immuno Cell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Immuno Cell Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Immuno Cell Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Immuno Cell Therapy Market
5.7 ESG Ratings of Leading Companies
6 Immuno Cell Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immuno Cell Therapy Sales Market Share by Type (2020-2025)
6.3 Global Immuno Cell Therapy Market Size Market Share by Type (2020-2025)
6.4 Global Immuno Cell Therapy Price by Type (2020-2025)
7 Immuno Cell Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immuno Cell Therapy Market Sales by Application (2020-2025)
7.3 Global Immuno Cell Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Immuno Cell Therapy Sales Growth Rate by Application (2020-2025)
8 Immuno Cell Therapy Market Sales by Region
8.1 Global Immuno Cell Therapy Sales by Region
8.1.1 Global Immuno Cell Therapy Sales by Region
8.1.2 Global Immuno Cell Therapy Sales Market Share by Region
8.2 Global Immuno Cell Therapy Market Size by Region
8.2.1 Global Immuno Cell Therapy Market Size by Region
8.2.2 Global Immuno Cell Therapy Market Size Market Share by Region
8.3 North America
8.3.1 North America Immuno Cell Therapy Sales by Country
8.3.2 North America Immuno Cell Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Immuno Cell Therapy Sales by Country
8.4.2 Europe Immuno Cell Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Immuno Cell Therapy Sales by Region
8.5.2 Asia Pacific Immuno Cell Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Immuno Cell Therapy Sales by Country
8.6.2 South America Immuno Cell Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Immuno Cell Therapy Sales by Region
8.7.2 Middle East and Africa Immuno Cell Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Immuno Cell Therapy Market Production by Region
9.1 Global Production of Immuno Cell Therapy by Region(2020-2025)
9.2 Global Immuno Cell Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Immuno Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Immuno Cell Therapy Production
9.4.1 North America Immuno Cell Therapy Production Growth Rate (2020-2025)
9.4.2 North America Immuno Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Immuno Cell Therapy Production
9.5.1 Europe Immuno Cell Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Immuno Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Immuno Cell Therapy Production (2020-2025)
9.6.1 Japan Immuno Cell Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Immuno Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Immuno Cell Therapy Production (2020-2025)
9.7.1 China Immuno Cell Therapy Production Growth Rate (2020-2025)
9.7.2 China Immuno Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 MEDINET Co
10.1.1 MEDINET Co Basic Information
10.1.2 MEDINET Co Immuno Cell Therapy Product Overview
10.1.3 MEDINET Co Immuno Cell Therapy Product Market Performance
10.1.4 MEDINET Co Business Overview
10.1.5 MEDINET Co SWOT Analysis
10.1.6 MEDINET Co Recent Developments
10.2 Erytech
10.2.1 Erytech Basic Information
10.2.2 Erytech Immuno Cell Therapy Product Overview
10.2.3 Erytech Immuno Cell Therapy Product Market Performance
10.2.4 Erytech Business Overview
10.2.5 Erytech SWOT Analysis
10.2.6 Erytech Recent Developments
10.3 Seta Clinic Group
10.3.1 Seta Clinic Group Basic Information
10.3.2 Seta Clinic Group Immuno Cell Therapy Product Overview
10.3.3 Seta Clinic Group Immuno Cell Therapy Product Market Performance
10.3.4 Seta Clinic Group Business Overview
10.3.5 Seta Clinic Group SWOT Analysis
10.3.6 Seta Clinic Group Recent Developments
10.4 Takeda
10.4.1 Takeda Basic Information
10.4.2 Takeda Immuno Cell Therapy Product Overview
10.4.3 Takeda Immuno Cell Therapy Product Market Performance
10.4.4 Takeda Business Overview
10.4.5 Takeda Recent Developments
10.5 SBI Holdings
10.5.1 SBI Holdings Basic Information
10.5.2 SBI Holdings Immuno Cell Therapy Product Overview
10.5.3 SBI Holdings Immuno Cell Therapy Product Market Performance
10.5.4 SBI Holdings Business Overview
10.5.5 SBI Holdings Recent Developments
10.6 Oxford BioTherapeutics
10.6.1 Oxford BioTherapeutics Basic Information
10.6.2 Oxford BioTherapeutics Immuno Cell Therapy Product Overview
10.6.3 Oxford BioTherapeutics Immuno Cell Therapy Product Market Performance
10.6.4 Oxford BioTherapeutics Business Overview
10.6.5 Oxford BioTherapeutics Recent Developments
10.7 Fate Therapeutics
10.7.1 Fate Therapeutics Basic Information
10.7.2 Fate Therapeutics Immuno Cell Therapy Product Overview
10.7.3 Fate Therapeutics Immuno Cell Therapy Product Market Performance
10.7.4 Fate Therapeutics Business Overview
10.7.5 Fate Therapeutics Recent Developments
10.8 Gilead Sciences
10.8.1 Gilead Sciences Basic Information
10.8.2 Gilead Sciences Immuno Cell Therapy Product Overview
10.8.3 Gilead Sciences Immuno Cell Therapy Product Market Performance
10.8.4 Gilead Sciences Business Overview
10.8.5 Gilead Sciences Recent Developments
10.9 Novartis
10.9.1 Novartis Basic Information
10.9.2 Novartis Immuno Cell Therapy Product Overview
10.9.3 Novartis Immuno Cell Therapy Product Market Performance
10.9.4 Novartis Business Overview
10.9.5 Novartis Recent Developments
10.10 Osiris
10.10.1 Osiris Basic Information
10.10.2 Osiris Immuno Cell Therapy Product Overview
10.10.3 Osiris Immuno Cell Therapy Product Market Performance
10.10.4 Osiris Business Overview
10.10.5 Osiris Recent Developments
10.11 Vericel Corporation
10.11.1 Vericel Corporation Basic Information
10.11.2 Vericel Corporation Immuno Cell Therapy Product Overview
10.11.3 Vericel Corporation Immuno Cell Therapy Product Market Performance
10.11.4 Vericel Corporation Business Overview
10.11.5 Vericel Corporation Recent Developments
10.12 Fujifilm Cellular Dynamics
10.12.1 Fujifilm Cellular Dynamics Basic Information
10.12.2 Fujifilm Cellular Dynamics Immuno Cell Therapy Product Overview
10.12.3 Fujifilm Cellular Dynamics Immuno Cell Therapy Product Market Performance
10.12.4 Fujifilm Cellular Dynamics Business Overview
10.12.5 Fujifilm Cellular Dynamics Recent Developments
10.13 JCR Pharmaceuticals
10.13.1 JCR Pharmaceuticals Basic Information
10.13.2 JCR Pharmaceuticals Immuno Cell Therapy Product Overview
10.13.3 JCR Pharmaceuticals Immuno Cell Therapy Product Market Performance
10.13.4 JCR Pharmaceuticals Business Overview
10.13.5 JCR Pharmaceuticals Recent Developments
10.14 Beike Biotechnology
10.14.1 Beike Biotechnology Basic Information
10.14.2 Beike Biotechnology Immuno Cell Therapy Product Overview
10.14.3 Beike Biotechnology Immuno Cell Therapy Product Market Performance
10.14.4 Beike Biotechnology Business Overview
10.14.5 Beike Biotechnology Recent Developments
10.15 Golden Meditech
10.15.1 Golden Meditech Basic Information
10.15.2 Golden Meditech Immuno Cell Therapy Product Overview
10.15.3 Golden Meditech Immuno Cell Therapy Product Market Performance
10.15.4 Golden Meditech Business Overview
10.15.5 Golden Meditech Recent Developments
10.16 Guanhao Biotech
10.16.1 Guanhao Biotech Basic Information
10.16.2 Guanhao Biotech Immuno Cell Therapy Product Overview
10.16.3 Guanhao Biotech Immuno Cell Therapy Product Market Performance
10.16.4 Guanhao Biotech Business Overview
10.16.5 Guanhao Biotech Recent Developments
10.17 Beroni Group
10.17.1 Beroni Group Basic Information
10.17.2 Beroni Group Immuno Cell Therapy Product Overview
10.17.3 Beroni Group Immuno Cell Therapy Product Market Performance
10.17.4 Beroni Group Business Overview
10.17.5 Beroni Group Recent Developments
11 Immuno Cell Therapy Market Forecast by Region
11.1 Global Immuno Cell Therapy Market Size Forecast
11.2 Global Immuno Cell Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Immuno Cell Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Immuno Cell Therapy Market Size Forecast by Region
11.2.4 South America Immuno Cell Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Immuno Cell Therapy by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Immuno Cell Therapy Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Immuno Cell Therapy by Type (2026-2033)
12.1.2 Global Immuno Cell Therapy Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Immuno Cell Therapy by Type (2026-2033)
12.2 Global Immuno Cell Therapy Market Forecast by Application (2026-2033)
12.2.1 Global Immuno Cell Therapy Sales (K Units) Forecast by Application
12.2.2 Global Immuno Cell Therapy Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings
